Signaling pathways controlling skeletal muscle mass
暂无分享,去创建一个
[1] B. Drake. Differential Response , 2013 .
[2] J. Darlix,et al. Conducting the initiation of protein synthesis: the role of eIF4G , 2003, Biology of the cell.
[3] Dudley Lamming,et al. Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity , 2012, Science.
[4] G. Yancopoulos,et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo , 2001, Nature Cell Biology.
[5] Da-Zhi Wang,et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. , 2004, The Journal of clinical investigation.
[6] A. Sanchez,et al. eIF3f: A central regulator of the antagonism atrophy/hypertrophy in skeletal muscle☆ , 2013, The International Journal of Biochemistry & Cell Biology.
[7] M. Hall,et al. Differential response of skeletal muscles to mTORC1 signaling during atrophy and hypertrophy , 2013, Skeletal Muscle.
[8] B. Spiegelman. Peroxisome Proliferator-Activated Receptor-Coactivator 1 ( PGC-1 ) : Transcriptional Coactivator and Metabolic Regulator , 2003 .
[9] N. LeBrasseur,et al. Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. , 2008, Cell metabolism.
[10] G. Yancopoulos,et al. Conditional Activation of Akt in Adult Skeletal Muscle Induces Rapid Hypertrophy , 2004, Molecular and Cellular Biology.
[11] D. Allen,et al. Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. , 2011, American journal of physiology. Cell physiology.
[12] A. Goldberg,et al. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.
[13] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[14] M. Greenwood,et al. Peptide and non-peptide G-protein coupled receptors (GPCRs) in skeletal muscle , 2005, Peptides.
[15] P. Freemont,et al. The RING finger domain: a recent example of a sequence-structure family. , 1996, Current opinion in structural biology.
[16] Se-Jin Lee,et al. Regulation of myostatin activity and muscle growth , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Kasuga,et al. Regulation of eIF-4E BP1 Phosphorylation by mTOR* , 1997, The Journal of Biological Chemistry.
[18] T. Hunter,et al. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. , 1999, Science.
[19] A. Goldberg,et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] Shuo Lin,et al. Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy. , 2013, Cell metabolism.
[21] D. Glass,et al. Molecular mechanisms and treatment options for muscle wasting diseases. , 2011, Annual review of pharmacology and toxicology.
[22] S. Bodine,et al. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. , 2008, American journal of physiology. Endocrinology and metabolism.
[23] A. Csibi,et al. MAFbx/Atrogin-1 Controls the Activity of the Initiation Factor eIF3-f in Skeletal Muscle Atrophy by Targeting Multiple C-terminal Lysines* , 2009, Journal of Biological Chemistry.
[24] Valerie Horsley,et al. Calcineurin Activity Is Required for the Initiation of Skeletal Muscle Differentiation , 2000, The Journal of cell biology.
[25] M. E. Lynch,et al. Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats. , 1994, Metabolism: clinical and experimental.
[26] During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation , 2009, The Journal of cell biology.
[27] J. Devesa,et al. Myostatin regulates cell survival during C2C12 myogenesis. , 2001, Biochemical and biophysical research communications.
[28] H. Katus,et al. Phosphorylation of Eukaryotic Translation Initiation Factor 2Bε by Glycogen Synthase Kinase-3β Regulates β-Adrenergic Cardiac Myocyte Hypertrophy , 2004, Circulation research.
[29] K. Esser,et al. FoxO1 induces apoptosis in skeletal myotubes in a DNA-binding-dependent manner. , 2009, American journal of physiology. Cell physiology.
[30] D. Dias-Santagata,et al. The CUL7 E3 ubiquitin ligase targets insulin receptor substrate 1 for ubiquitin-dependent degradation. , 2008, Molecular cell.
[31] S. Bodine,et al. Rapamycin inhibits the growth and muscle-sparing effects of clenbuterol. , 2007, Journal of applied physiology.
[32] Adrian V. Lee,et al. Insulin-Like Growth Factor I-Induced Degradation of Insulin Receptor Substrate 1 Is Mediated by the 26S Proteasome and Blocked by Phosphatidylinositol 3′-Kinase Inhibition , 2000, Molecular and Cellular Biology.
[33] Jiong Wu,et al. Molecular Mechanism of Insulin-Induced Degradation of Insulin Receptor Substrate 1 , 2002, Molecular and Cellular Biology.
[34] I. Nonaka,et al. Ubiquitin Ligase Cbl-b Is a Negative Regulator for Insulin-Like Growth Factor 1 Signaling during Muscle Atrophy Caused by Unloading , 2009, Molecular and Cellular Biology.
[35] Eric Karsenti,et al. Transient association of titin and myosin with microtubules in nascent myofibrils directed by the MURF2 RING-finger protein , 2002, Journal of Cell Science.
[36] M. Palacín,et al. Evidence for a Mitochondrial Regulatory Pathway Defined by Peroxisome Proliferator–Activated Receptor-γ Coactivator-1α, Estrogen-Related Receptor-α, and Mitofusin 2 , 2006, Diabetes.
[37] C. Gregorio,et al. Functional properties of the titin/connectin-associated proteins, the muscle-specific RING finger proteins (MURFs), in striated muscle , 2006, Journal of Muscle Research & Cell Motility.
[38] M. Febbraio,et al. FOXO1 Regulates the Expression of 4E-BP1 and Inhibits mTOR Signaling in Mammalian Skeletal Muscle* , 2007, Journal of Biological Chemistry.
[39] A. Gingras,et al. Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.
[40] V. Hughes,et al. Sarcopenia: current concepts. , 2000, The journals of gerontology. Series A, Biological sciences and medical sciences.
[41] E. Ganio,et al. Trip12, a HECT domain E3 ubiquitin ligase, targets Sox6 for proteasomal degradation and affects fiber type-specific gene expression in muscle cells , 2013, Skeletal Muscle.
[42] A. Gingras,et al. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. , 1998, Genes & development.
[43] T. Haystead,et al. PHAS proteins as mediators of the actions of insulin, growth factors and cAMP on protein synthesis and cell proliferation. , 1997, Advances in enzyme regulation.
[44] D. Sabatini,et al. mTORC1 Phosphorylation Sites Encode Their Sensitivity to Starvation and Rapamycin , 2013, Science.
[45] S. Hatakeyama,et al. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. , 2009, American journal of physiology. Cell physiology.
[46] G. Pavlath,et al. Regulation of the Growth of Multinucleated Muscle Cells by an Nfatc2-Dependent Pathway , 2001, The Journal of cell biology.
[47] N. Offner,et al. The initiation factor eIF3‐f is a major target for Atrogin1/MAFbx function in skeletal muscle atrophy , 2008, The EMBO journal.
[48] S. Gygi,et al. Genomic and Proteomic Profiling Reveals Reduced Mitochondrial Function and Disruption of the Neuromuscular Junction Driving Rat Sarcopenia , 2012, Molecular and Cellular Biology.
[49] Michel Georges,et al. A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle , 1997, Nature Genetics.
[50] H. Horiuchi. Seven-transmembrane receptors , 2015 .
[51] A. Goldberg,et al. Peroxisome Proliferator-activated Receptor γ Coactivator 1α or 1β Overexpression Inhibits Muscle Protein Degradation, Induction of Ubiquitin Ligases, and Disuse Atrophy* , 2010, The Journal of Biological Chemistry.
[52] C. Gregorio,et al. Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1 , 2002, The Journal of cell biology.
[53] P. Hasselgren,et al. Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism. , 2010, The international journal of biochemistry & cell biology.
[54] Se-Jin Lee,et al. Double muscling in cattle due to mutations in the myostatin gene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[55] J. Durigan,et al. Joint Inflammation Alters Gene and Protein Expression and Leads to Atrophy in the Tibialis Anterior Muscle in Rats , 2011, American journal of physical medicine & rehabilitation.
[56] D. Guertin,et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. , 2006, Developmental cell.
[57] W. Frontera,et al. IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice , 2004, Cell.
[58] K. Pelin,et al. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. , 2001, Journal of molecular biology.
[59] Se-Jin Lee,et al. Myostatin and the control of skeletal muscle mass. , 1999, Current opinion in genetics & development.
[60] Wen Dui,et al. MST1, a key player, in enhancing fast skeletal muscle atrophy , 2013, BMC Biology.
[61] Y. Pi,et al. Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders , 2013, Nature.
[62] P. Puigserver,et al. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. , 2003, Endocrine reviews.
[63] E. Wouters,et al. NF-κB activation is required for the transition of pulmonary inflammation to muscle atrophy. , 2012, American journal of respiratory cell and molecular biology.
[64] Seumas McCroskery,et al. Myostatin negatively regulates satellite cell activation and self-renewal , 2003, The Journal of cell biology.
[65] D. Glass,et al. The SCF-Fbxo40 complex induces IRS1 ubiquitination in skeletal muscle, limiting IGF1 signaling. , 2011, Developmental cell.
[66] C. Mammucari,et al. Smad2 and 3 transcription factors control muscle mass in adulthood. , 2009, American journal of physiology. Cell physiology.
[67] D. Béchet,et al. Leucine Limitation Induces Autophagy and Activation of Lysosome-dependent Proteolysis in C2C12 Myotubes through a Mammalian Target of Rapamycin-independent Signaling Pathway* , 2000, The Journal of Biological Chemistry.
[68] Metformin, metabolic stress, and mitochondria. Focus on "A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells". , 2012, American journal of physiology. Cell physiology.
[69] W. Frontera,et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. , 2004, Cell.
[70] Zhijian Lu,et al. Regulation of GDF-8 signaling by the p38 MAPK. , 2005, Cellular signalling.
[71] D. Sabatini,et al. Redox Regulation of the Nutrient-sensitive Raptor-mTOR Pathway and Complex* , 2005, Journal of Biological Chemistry.
[72] Christine C. Hudson,et al. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. , 1997, Science.
[73] B. Spiegelman,et al. Increased muscle PGC-1α expression protects from sarcopenia and metabolic disease during aging , 2009, Proceedings of the National Academy of Sciences.
[74] Stefan Offermanns,et al. Mammalian G proteins and their cell type specific functions. , 2005, Physiological reviews.
[75] J. Blenis,et al. TOS Motif-Mediated Raptor Binding Regulates 4E-BP1 Multisite Phosphorylation and Function , 2003, Current Biology.
[76] W. Bauman,et al. Dependence of dexamethasone-induced Akt/FOXO1 signaling, upregulation of MAFbx, and protein catabolism upon the glucocorticoid receptor. , 2009, Biochemical and biophysical research communications.
[77] K. Chihara,et al. Branched-chain amino acids and arginine suppress MaFbx/atrogin-1 mRNA expression via mTOR pathway in C2C12 cell line. , 2008, Biochimica et biophysica acta.
[78] Se-Jin Lee,et al. Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11 , 1999, Nature Genetics.
[79] S. Walrand,et al. Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic β‐adrenoceptor stimulation in mice , 2010, The Journal of physiology.
[80] Jun Sub Park,et al. MG53-induced IRS-1 ubiquitination negatively regulates skeletal myogenesis and insulin signalling , 2013, Nature Communications.
[81] E. Kudryashova,et al. Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin. , 2005, Journal of molecular biology.
[82] M. Azain,et al. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. , 2002, Biochemical and biophysical research communications.
[83] C. Pellegrino,et al. AN ELECTRON MICROSCOPE STUDY OF DENERVATION ATROPHY IN RED AND WHITE SKELETAL MUSCLE FIBERS , 1963, The Journal of cell biology.
[84] D. Sabatini,et al. mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery , 2002, Cell.
[85] G. Lynch,et al. Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease. , 2008, Physiological reviews.
[86] S. Gygi,et al. Ubiquitylation by Trim32 causes coupled loss of desmin, Z-bands, and thin filaments in muscle atrophy , 2012, The Journal of cell biology.
[87] P. Hasselgren,et al. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. , 2003, The international journal of biochemistry & cell biology.
[88] E. Hafen,et al. Autonomous Control of Cell and Organ Size by CHICO, a Drosophila Homolog of Vertebrate IRS1–4 , 1999, Cell.
[89] Robert J. Schwartz,et al. Myogenic Vector Expression of Insulin-like Growth Factor I Stimulates Muscle Cell Differentiation and Myofiber Hypertrophy in Transgenic Mice (*) , 1995, The Journal of Biological Chemistry.
[90] T. Tarragó,et al. Comparative effects of beta2-adrenergic agonists on muscle waste associated with tumour growth. , 1997, Cancer letters.
[91] V. Mootha,et al. Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.
[92] V. Almendro,et al. The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia. , 2007, International journal of oncology.
[93] L. Tessitore,et al. Muscle protein waste in tumor-bearing rats is effectively antagonized by a beta 2-adrenergic agonist (clenbuterol). Role of the ATP-ubiquitin-dependent proteolytic pathway. , 1995, The Journal of clinical investigation.
[94] D. Allen,et al. Myostatin up-regulation is associated with the skeletal muscle response to hypoxic stimuli , 2011, Molecular and Cellular Endocrinology.
[95] A. Marette,et al. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells. , 2001, The Journal of biological chemistry.
[96] M. Greenberg,et al. Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor , 1999, Cell.
[97] J. Garin,et al. Characterization of a novel RNA‐binding region of eIF4GI critical for ribosomal scanning , 2003, The EMBO journal.
[98] Andrea M. Hanson,et al. CCAAT/enhancer binding protein-delta expression is increased in fast skeletal muscle by food deprivation and regulates myostatin transcription in vitro. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.
[99] P. Cohen,et al. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase‐1 and p70 S6 kinase , 1996, FEBS letters.
[100] S. Elledge,et al. A family of mammalian F-box proteins , 1999, Current Biology.
[101] Keiichi Fukuda,et al. Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. , 2011, Cell metabolism.
[102] C. Berset,et al. The TOR (target of rapamycin) signal transduction pathway regulates the stability of translation initiation factor eIF4G in the yeast Saccharomyces cerevisiae. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[103] Marco Sandri,et al. Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.
[104] P. Gluckman,et al. The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. , 2012, Cell metabolism.
[105] A. Gingras,et al. Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E , 1999, The EMBO journal.
[106] J. Wrana,et al. Myostatin Signals through a Transforming Growth Factor β-Like Signaling Pathway To Block Adipogenesis , 2003, Molecular and Cellular Biology.
[107] Antonio Musarò,et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle , 2001, Nature Genetics.
[108] T. Hornberger,et al. Faculty Opinions recommendation of Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. , 2014 .
[109] P. Cohen,et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.
[110] Se-Jin Lee,et al. Quadrupling Muscle Mass in Mice by Targeting TGF-ß Signaling Pathways , 2007, PloS one.
[111] G. Crabtree,et al. NFAT Signaling Choreographing the Social Lives of Cells , 2002, Cell.
[112] S. Bhatnagar,et al. The TWEAK–Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice , 2010, The Journal of cell biology.
[113] G. Meroni,et al. TRIM/RBCC, a novel class of ‘single protein RING finger’ E3 ubiquitin ligases , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.
[114] C. Reggiani,et al. Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[115] Holly McDonough,et al. Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins. , 2007, The Journal of clinical investigation.
[116] M. Sandri. Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome☆☆☆ , 2013, The international journal of biochemistry & cell biology.
[117] O. Mayans,et al. Structural analysis of B-Box 2 from MuRF1: identification of a novel self-association pattern in a RING-like fold. , 2008, Biochemistry.
[118] P. Freemont,et al. Does this have a familiar RING? , 1996, Trends in biochemical sciences.
[119] S. Rakhilin,et al. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. , 2007, Cell metabolism.
[120] J. Tong,et al. AMP‐activated protein kinase enhances the expression of muscle‐specific ubiquitin ligases despite its activation of IGF‐1/Akt signaling in C2C12 myotubes , 2009, Journal of cellular biochemistry.
[121] S. Elledge,et al. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. , 1999, Science.
[122] D. Bolster,et al. AMP-activated Protein Kinase Suppresses Protein Synthesis in Rat Skeletal Muscle through Down-regulated Mammalian Target of Rapamycin (mTOR) Signaling* , 2002, The Journal of Biological Chemistry.
[123] G. Condorelli,et al. The Akt-Glycogen Synthase Kinase 3β Pathway Regulates Transcription of Atrial Natriuretic Factor Induced by β-Adrenergic Receptor Stimulation in Cardiac Myocytes* , 2000, The Journal of Biological Chemistry.
[124] H. Granzier,et al. MuRF1 is a muscle fiber-type II associated factor and together with MuRF2 regulates type-II fiber trophicity and maintenance. , 2010, Journal of structural biology.
[125] M. White,et al. SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2* , 2002, The Journal of Biological Chemistry.
[126] M. Fornaro,et al. Gαi2 Signaling Promotes Skeletal Muscle Hypertrophy, Myoblast Differentiation, and Muscle Regeneration , 2011, Science Signaling.
[127] S. Welle,et al. Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice. , 2009, American journal of physiology. Endocrinology and metabolism.
[128] A. Goldberg,et al. FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.
[129] R. Berdeaux,et al. cAMP signaling in skeletal muscle adaptation: hypertrophy, metabolism, and regeneration. , 2012, American journal of physiology. Endocrinology and metabolism.
[130] A. Russell,et al. Peroxisome Proliferator-activated Receptor γ Coactivator 1 (PGC-1)- and Estrogen-related Receptor (ERR)-induced Regulator in Muscle 1 (PERM1) Is a Tissue-specific Regulator of Oxidative Capacity in Skeletal Muscle Cells* , 2013, The Journal of Biological Chemistry.
[131] Jiandie D. Lin,et al. PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription , 2006, Proceedings of the National Academy of Sciences.
[132] Se-Jin Lee,et al. Suppression of body fat accumulation in myostatin-deficient mice. , 2002, The Journal of clinical investigation.
[133] A. Goldberg,et al. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. , 2007, Cell metabolism.
[134] B. Viollet,et al. Important role for AMPKαl in limiting skeletal muscle cell hypertrophy , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[135] Daiwen Chen,et al. Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells. , 2007, Cellular signalling.
[136] G. Scheper,et al. The Mitogen-Activated Protein Kinase Signal-Integrating Kinase Mnk2 Is a Eukaryotic Initiation Factor 4E Kinase with High Levels of Basal Activity in Mammalian Cells , 2001, Molecular and Cellular Biology.
[137] J. Lagirand-Cantaloube,et al. Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo , 2009, PloS one.
[138] Valerie Horsley,et al. NFAT: ubiquitous regulator of cell differentiation and adaptation. , 2002, The Journal of cell biology.
[139] Sherry Chin,et al. MNK2 Inhibits eIF4G Activation Through a Pathway Involving Serine-Arginine–Rich Protein Kinase in Skeletal Muscle , 2012, Science Signaling.
[140] R. Roubenoff,et al. Recent advances in the biology and therapy of muscle wasting , 2010, Annals of the New York Academy of Sciences.
[141] J. Olefsky,et al. A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1. , 2000, Molecular endocrinology.
[142] Christian C Witt,et al. Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2 , 2007, The EMBO journal.
[143] C. Jacobi,et al. TAK-1/p38/nNFκB signaling inhibits myoblast differentiation by increasing levels of Activin A , 2012, Skeletal Muscle.
[144] C. Greenberg,et al. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. , 2002, American journal of human genetics.
[145] C. Rommel,et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways , 2001, Nature Cell Biology.
[146] D. Guertin,et al. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.
[147] Alexandros Tzatsos,et al. Nutrients Suppress Phosphatidylinositol 3-Kinase/Akt Signaling via Raptor-Dependent mTOR-Mediated Insulin Receptor Substrate 1 Phosphorylation , 2006, Molecular and Cellular Biology.
[148] V. Sirri,et al. Degradation of MyoD Mediated by the SCF (MAFbx) Ubiquitin Ligase* , 2005, Journal of Biological Chemistry.
[149] Qicheng Ma,et al. Voluntary running, skeletal muscle gene expression, and signaling inversely regulated by orchidectomy and testosterone replacement. , 2011, American journal of physiology. Endocrinology and metabolism.
[150] G. Yancopoulos,et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.